Treatment for chronic myocardial infarct
US9517199B2 · kind B2 · utility
0Cited by
5References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2015 |
| Grant date | Dec 13, 2016 |
| Priority date | — |
| Expiry date | May 8, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.